Finance

Lists
Why is 009420 up 2,73%?
Dive Deeper
009420:KRX
Hanall Biopharma Co Ltd
43 300,00 KRW
+2,73%
(+1 150,00) 1D
19 ოქტ, 15:30:24 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 009420...
Open
41 300 KRW
High
43 300 KRW
Low
41 050 KRW
Mkt. cap
2,26 ტრლ.
Avg. vol.
241,84 ათ.
Volume
159,91 ათ.
52-wk high
73 000 KRW
52-wk low
32 600 KRW
EPS
-490 KRW
Shares outstanding
52,24 მლნ.
No. of employees
287
Open
41 300 KRW
High
43 300 KRW
Low
41 050 KRW
Mkt. cap
2,26 ტრლ.
Avg. vol.
241,84 ათ.
Volume
159,91 ათ.
52-wk high
73 000 KRW
52-wk low
32 600 KRW
EPS
-490 KRW
Shares outstanding
52,24 მლნ.
No. of employees
287
News stories
From web sources and news partners
About Hanall Biopharma Co Ltd
CEOიუნ ჯეი-ჩუნ | სეუნგ კოუკ პარკ
Employees287
Founded1973
Headquartersსეული, Gangnam District, სამხრეთ კორეა
SectorPharmaceutical industry
Websitehanall.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
40,80 მლრდ.
37,55 მლრდ.
40,03 მლრდ.
44,28 მლრდ.
Cost of goods sold
19,78 მლრდ.
18,91 მლრდ.
18,72 მლრდ.
19,51 მლრდ.
Cost of revenue
19,78 მლრდ.
18,91 მლრდ.
18,72 მლრდ.
19,51 მლრდ.
Research and development expenses
4,77 მლრდ.
3,58 მლრდ.
3,52 მლრდ.
3,72 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15,62 მლრდ.
16,79 მლრდ.
16,64 მლრდ.
15,15 მლრდ.
Operating expense
20,68 მლრდ.
21,35 მლრდ.
20,47 მლრდ.
19,32 მლრდ.
Total operating expenses
40,45 მლრდ.
40,26 მლრდ.
39,19 მლრდ.
38,83 მლრდ.
Operating income
348,88 მლნ.
-2,71 მლრდ.
838,73 მლნ.
5,45 მლრდ.
Other non operating income
66,15 მლნ.
91,23 მლნ.
566,24 მლნ.
-10,89 მლრდ.
EBT including unusual items
342,71 მლნ.
-7,16 მლრდ.
570,24 მლნ.
-21,50 მლრდ.
EBT excluding unusual items
324,21 მლნ.
-2,74 მლრდ.
570,24 მლნ.
-5,85 მლრდ.
Income tax expense
43,75 მლნ.
-912,20 მლნ.
295,24 მლნ.
-2,27 მლრდ.
Effective tax rate
12,77%
12,74%
51,77%
10,57%
Other operating expenses
170,57 მლნ.
159,83 მლნ.
178,41 მლნ.
160,81 მლნ.
Net income
298,96 მლნ.
-6,25 მლრდ.
275,00 მლნ.
-19,23 მლრდ.
Net profit margin
0,73%
-16,64%
0,69%
-43,43%
Earnings per share
-
-
-
-
Interest and investment income
62,64 მლნ.
52,44 მლნ.
138,01 მლნ.
204,61 მლნ.
Interest expense
-20,18 მლნ.
-80,02 მლნ.
-372,72 მლნ.
-418,03 მლნ.
Net interest expenses
42,46 მლნ.
-27,59 მლნ.
-234,71 მლნ.
-213,42 მლნ.
Depreciation and amortization charges
136,95 მლნ.
129,60 მლნ.
129,07 მლნ.
125,27 მლნ.
EBITDA
1,25 მლრდ.
-1,82 მლრდ.
1,67 მლრდ.
6,18 მლრდ.
Gain or loss from assets sale
-18,50 მლნ.
-4,84 მლნ.
-
319,09 მლნ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები